Skip to content

Clinical trials

Phase 3 Peripheral Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Nervous System Diseases Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20052
20061
20072
20081
20091
20101
20111
20151
20161
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeurogesX3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Pharnext S.C.A.2
Alliance for Clinical Trials in Oncology1
Baxalta now part of Shire1
Eastern Virginia Medical School1
Eli Lilly and Company1
Gary Morrow1
Gynecologic Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Nervous System Diseases19
Pain10
HIV Infections4
Neurotoxicity Syndromes4
Diabetic Neuropathies3
Polyneuropathies3
Charcot-Marie-Tooth Disease2
Diabetes Mellitus2
Neuralgia2
Autoimmune Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.